Kangzhou Medical Products has strong R&D capabilities and currently has a dedicated R&D team of 10 people, including 4 with doctoral or above degrees, 2 with master's degrees, and 4 with bachelor's degrees. The project leader has been engaged in the research and development and production management of in vitro diagnostic reagents for 17 years. The team members are all professionals in related fields, and have worked in internationally renowned in vitro diagnostic reagent units such as Hangzhou Aikang and Shengxiang Biology. They have rich experience in research and development and technology transformation.
Kangzhou Medical attaches great importance to cooperation between industry, academia, and research. It has conducted project development cooperation with pet hospitals of Huazhong Agricultural University, medical schools of Hubei University of Science and Technology, and other universities. Based on this, it has jointly established a joint training base for professional direct talent.
Kangzhou Medical has four leading domestic technology platforms in the field of in vitro diagnostic reagents: fluorescence quantitative chromatography (POCT), magnetic particle tube chemiluminescence, colloidal gold, and dry chemistry; The company's products cover over 60 in vitro diagnostic products for diseases applicable to companion animals (dogs, cats) and economic animals (pigs, cows, sheep, and poultry). The performance of the products has been comprehensively evaluated by multiple high-level laboratories and has been unanimously recognized.
Kangzhou Medical has four leading domestic technology platforms in the field of in vitro diagnostic reagents: fluorescence quantitative chromatography (POCT), magnetic particle tube chemiluminescence, colloidal gold, and dry chemistry
The company's products cover over 60 in vitro diagnostic products for diseases applicable to companion animals (dogs, cats) and economic animals (pigs, cows, sheep, and poultry). The performance of the products has been comprehensively evaluated by multiple high-level laboratories and has been unanimously recognized.
The company's products cover over 60 in vitro diagnostic products for diseases applicable to companion animals (dogs, cats) and economic animals (pigs, cows, sheep, and poultry). The performance of the products has been comprehensively evaluated by multiple high-level laboratories and has been unanimously recognized.
The company's products cover over 60 in vitro diagnostic products for diseases applicable to companion animals (dogs, cats) and economic animals (pigs, cows, sheep, and poultry). The performance of the products has been comprehensively evaluated by multiple high-level laboratories and has been unanimously recognized.
The company's products cover over 60 in vitro diagnostic products for diseases applicable to companion animals (dogs, cats) and economic animals (pigs, cows, sheep, and poultry). The performance of the products has been comprehensively evaluated by multiple high-level laboratories and has been unanimously recognized.
The company's products cover over 60 in vitro diagnostic products for diseases applicable to companion animals (dogs, cats) and economic animals (pigs, cows, sheep, and poultry). The performance of the products has been comprehensively evaluated by multiple high-level laboratories and has been unanimously recognized.
